logo BDSP

Base documentaire


  1. Activated protein C resistance and the FV : R506Q mutation in a random population sample : Associations with cardiovascular risk factors and coagulation variables.

    Article - En anglais

    Activated protein C (APC) resistance, defined as a low APC ratio, is associated with the factor V mutation R506Q (factor V Leiden).

    APC ratio may also be influenced by other clinical and coagulation variables, which we studied in 460 men and 495 women aged 25-74 years, from a random population sample (Glasgow MONICA Survey).

    APC ratio correlated positively with APTT ; and inversely with factor VIIIc, factor IXc, antithrombin activity, prothrombin F1+2 fragment, and thrombin-antithrombin complexes ; but not with other coagulation variables.

    APC ratio decreased with age, but APTT did not.

    APC ratio and APTT were significantly lower in women versus men, and were significantly lower in users of oral contraceptives or hormone replacement therapy.

    The FV : R506Q mutation (prevalence 2.5%) was associated with lower APC ratio and protein C and S activities and with higher factor VIIIc levels ; but not with increases in F1+2 fragment or thrombin-antithrombin complexes.

    APC ratio correlated inversely with total cholesterol and diastolic blood pressure ; and in women with triglycerides, systolic blood pressure, and body mass index.

    Obesity was associated with a significantly lower APC ratio.

    In contrast, smoking markers correlated positively with APC ratio in men.

    These associations of APC ratio may be relevant to the increased risks of venous thrombosis with age, female sex, oestrogen use, obesity and high factor VIIIc levels. (...)

    Mots-clés Pascal : Résistance, Protein C (activated), Serine endopeptidases, Peptidases, Hydrolases, Enzyme, Facteur V Leiden, Temps thromboplastine partielle, Test coagulation, Facteur coagulation, Facteur VIII procoagulant, Anticoagulant, Endogène, Cholestérol, Triglycéride, Pression sanguine, Contraceptif, Voie orale, Oestrogène, Hormone stéroïde, Obésité, Traitement substitutif, Coagulation sanguine, Marqueur biologique, Age, Sexe, Epidémiologie, Royaume Uni, Europe, Homme, Hémopathie, Coagulopathie, Maladie héréditaire, Lipide

    Mots-clés Pascal anglais : Resistance, Protein C (activated), Serine endopeptidases, Peptidases, Hydrolases, Enzyme, Factor V Leiden, Partial thromboplastin time, Coagulation test, Coagulation factor, Factor VIIIc, Anticoagulant, Endogenous, Cholesterol, Triglyceride, Blood pressure, Contraceptive, Oral administration, Estrogen, Steroid hormone, Obesity, Replacement therapy, Blood coagulation, Biological marker, Age, Sex, Epidemiology, United Kingdom, Europe, Human, Hemopathy, Coagulopathy, Genetic disease, Lipids

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0368847

    Code Inist : 002B19C. Création : 14/12/1999.